MEDITHERAPY
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MEDITHERAPY - overview
Established
2017
Location
Seoul, -, South Korea
Primary Industry
Consumer Products
About
Founded in 2017 and based in Seoul, South Korea, MEDITHERAPY provides products for pain and acupressure care, dry/moisturizing care, swelling/cool care, wrinkles, and many more. As of 2024, the company is headed by its CEO Seungjin Lee. In April 2024, the firm raised KRW 26 billion in series A funding led by new investor Company K Partners. Other new investors Investment Partners and DSC Investment also participated in the round.
The company offers a wide range of beauty products for the face and body. The firm product range includes contour management, Wrinkle Fit Perfume hand buttercream, Wrinkle Fit Tangle eye cream, Wrinkle Fit Tangle eye cream refill, shumage shot goldseal lifting ampoule, blue layer double water cream, and many many others. The company plans to use the April 2024 funding to distribute products to overseas markets.
Current Investors
Korea Investment Partners, DSC Investment, Company K Partners
Primary Industry
Consumer Products
Sub Industries
Beauty & Hygiene
Website
www.meditherapy.co.kr/
Verticals
E-commerce
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.